Abstract
Prostaglandins (PG) are potent biological mediators of thrombosis and the inflammatory response1,2. Prostaglandin endoperoxide H synthase, also referred to as cyclooxygenase (COX), is a bisfunctional protein, which catalyses the first committed step in the formation of PG and thromboxanes by the sequential cyclooxygenation and peroxidation of arachidonic acid (AA) to PGH2 3,4. PGH2 is then converted to specific PGs by distinct cell specific synthases or isomerases. Mammalian cells contain two isoforms of this enzyme, COX-1 and COX-2, which are encoded by separate genes, but they are structurally homologous and have similar kinetic properties5–7.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
FitzGerald GA. Prostaglandins and related compounds. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil Loeb Textbook of Medicine, 20th edn. Philadelphia: Saunders, 1995:1187–93.
Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J. 1989;259: 315–24.
Smith WL, Marnett U. Prostaglandin endoperoxide synthase: Structure and catalysis. Biochem Biophys Acta. 1990;1083:1–17.
Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol. 1992;263: F181–91.
Hla T, Neilson K. Human cyclooxygenase 2 cDNA. Proc Nat! Acad Sci USA. 1992;89:7384–8.
O’Bannion MK, Winn VD, Young DA. cDNA Cloning and functional activity of a glucocorticoidregulated inflammatory cyclooxygenase. Proc Nat! Acad Sci USA. 1992;89:4888–92.
Hsi LC, Hoganson CW, Babcock GT, Smith WL. Characterization of a tyrosyl radical in prostaglandin endoperoxide synthase-2. Biochem Biophys Res Commun. 1994;202:1592–8.
Yamagata K, Andreasson K, Kaufmann W, Barnes CA, Worley PE Expression of a mitogen inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 1993;11:371–86.
O’Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993;330:156–60.
Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265:16737–40.
Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest. 1990;86:1375–9.
Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, Hla T. CyclooxygenaseI and -2 expression in rheumatoid synovial tissues. J Clin Invest. 1994;93:1095–101.
Masferrer JL, Srinivasa TR, Zweifel BS, Seibert K, Needleman P, Gilbert RS, Herschman HR. In vivo glucocorticoids regulate cyclooxygenase- 1 but not cyclooxygenase- 1 in peritoneal macrophages. J Pharmacol Exp Ther. 1994;270:1340–4.
Mertz PM, DeWitt DL, Steller-Stevenson WG, Wahl LM. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J Biel Chem. 1994;269:21322–9.
Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson PC. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Nat! Acad Sci USA. 1994;91:12013–17.
Masferrer JL, Zweifel BS, Manning PT, Hauser S, Leahy KM, Smith WG, Isakson PC, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Nat! Acad Sci USA. 1994;91:3228–32.
Morham SC, Langenbach R, Loftin CD, Tiano HF et a1. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 1995;83:473–82.
Langenbach R, Morham SG, Tiano HF, Loftin CD, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 1995;83:483–92.
Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology. 1993;187:403–16.
Suffredini AF, Fromm E, Parker MM et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280–7.
Michie HR, Maogue PC, Spriggs DR, Revhaug A et al. Detection of circulating tumour necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481–6.
Cassale TB, Ballas ZK, Kaliner MA, Keahey TM. The effects of intravenous endotoxin on various host effector molecules. J Allergy Clin Immunol. 1990;85:45–51.
Suffredini AF, Harpel PC, Parillo JE. Promotion and subsequent inhibition of plasminogen activator after administration of intravenous endotoxin to normal subjects. N Engl J Med. 1989; 320:1165–72.
Rodrick ML, Moss NM, Grbic JT et al. Effects of endotoxin infusions on the in vitro cellular immune responses in humans. J Clin Immunol. 1992;12:440–50.
Spins GA, Bloesch D, Keller U, Zimmerli W, Cammisuli S. Pretreatment with ibuprofen augments circulating tumour necrosis factor a, interleukin-6, and elastase during acute endotoxaemia. J Infect Dis. 1991;163:89–95.
Martich GD, Parker MM, Cunnion RE, Suffredini AF. Effects of ibuprofen and pentoxifylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol. 1992;73:925–31
FitzGerald GA, Brash AR. Blair IA, Lawson J. Analysis of urinary metabolites of thromboxane and prostacyclin by negative ion chemical ionization gas chromatography-mass spectrometry. In: Hayaishi O, Yamamoto S, eds. Advances in Prostaglandin, Thromboxane and Leukotriene Research. New York: Raven Press, 1985:87–90.
Catella F, Johnson JM, FitzGerald GA. Quantitative analysis of eicosanoids by gas chromatography-mass spectrometry. In: Samuelsson BB, Berti F, Folco G, Velo GP, editors. Prostanoids and Drugs. New York: Plenum Press (NATO ASI Series). 1989:15–22.
Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase 2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504–10.
O’Sullivan MG, Huggins EM, Meade EA, DeWitt D, McCall CE. Lipopolysaccharide induces prostaglandin H synthase 2 in alveolar macrophages. Biochem Biophys Res Commun. 1992; 187:1123–7.
Lee SH, Soyoola E, Chanmugam P, Hart S, et al. Selective expression of mitogen inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992;267: 25934–8.
Van der Poll T, Van Deventer SJ, Buller HR, et al. Comparison of the early dynamics of systemic prostacyclin release after administration of tumour necrosis factor and endotoxin to healthy humans. J Infect Dis. 1991;164:599–601.
Pedersen AK, Watson M, FitzGerald GA. Inhibition of thromboxane synthase in serum: limitations of the measurement of immunoreactive 6 keto-PGF1α. Thrombosis Res. 1983;33:99–103.
Wright SD, Ramos PS, Tobias RJ, Ulevitch RJ, Mathison JC. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 190;249:1431.
Leeuwenberg JF, Dentener MA, Buurman WA. Lipopolysaccharide LPS-mediated soluble TNR receptor release and TNF receptor expression by monocytes. J Immunol. 1994;152:5070–6.
Vane JR, Botting RM. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). Adv Pros Thromb Leuk Res. 1995;23:41–8.
Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase 2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 1994; 93:391–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
McAdam, B.F., Fitzgerald, G.A. (1996). Enzymatic regulation of the prostaglandin response in a human model of inflammation. In: Bazan, N., Botting, J., Vane, J. (eds) New Targets in Inflammation. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5386-7_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-5386-7_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6265-7
Online ISBN: 978-94-011-5386-7
eBook Packages: Springer Book Archive